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ABstRACt
Objective: Ameloblastoma is a benign odontogenic tumor (OT) originating from the proliferation of 
odontogenic epithelium without involvement of the mesenchymal tissue. The aims of the present 
study were to perform a retrospective analysis of ameloblastoma, compare the findings with those 
described in previous studies and outline the epidemiological profile of this type of tumor in southern 
Brazilian population. 
Methods: Cases of ameloblastoma were retrieved between 1954 and 2009 from a single center and 
analyzed for age, gender, ethnic, primary site and histological type. Cases were classified according 
to the 2005 WHO classification of OTs. 
Results: Descriptive statistical analysis of the data was performed, with the determination of the 
frequency of the categorical variables. Eighty-nine cases of ameloblastoma were found: 78 cases 
of solid tumor (88.6%), two cases of desmoplastic tumor (2.2%) and nine cases of the unicystic 
tumor (10.2%). There was a predominance of the female gender (58.4%) and Caucasian ethnicity 
(62.9%). Most ameloblastomas were located in the mandible (78.6%) and 40.2% occurred prior to 
the third decade of life. 
Conclusion: The present findings are in agreement with those reported in previous studies carried 
out in other states of Brazil and support that notion that there may be a geographical influence on 
the profile of patients affected by ameloblastoma.
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Aspectos clinico-patológicos de ameloblastomas no sul do Brasil: 
55 anos de uma única Instituição
ResuMO
Introdução: Ameloblastoma é uma neoplasia odontogênica benigna (NOB) que se origina da proliferação do 
epitélio odontogênico sem envolvimento do mesênquima. Os objetivos do presente estudo foram realizar uma 
análise retrospectiva do ameloblastoma, comparar os resultados com os descritos em estudos anteriores e 
traçar o perfil epidemiológico deste tipo de tumor na população do sul do Brasil.
Metodologia: Casos de ameloblastoma diagnosticados entre 1954 e 2009 em um único centro foram analisados 
quanto á idade, sexo, etnia, localização e tipo histológico. Os casos foram classificados de acordo com a 
classificação da OMS de 2005 de NOBs.
Resultados: Foi realizada análise estatística descritiva dos dados com a determinação da freqüência das 
variáveis categóricas. Oitenta e nove casos de ameloblastomas foram diagnosticados: 78 casos corresponderam 
ao tipo sólido (88.6%), dois casos ao tipo desmoplásico (2.2%) e nove casos ao tipo unicístico (10.2%). Houve 
predomínio pelo gênero feminine (58.4%) e de etnia branca (62.9%). A maioria localizou-se na mandíbula (78.6%) 
e 40.2% ocorreram preferencialmente na terceira década de vida.
Conclusão: Nossos achados estão de acordo com os achados realizados em outros estados do Brasil. Isto 
mostra que pode ocorrer uma influência geográfica sobre o perfil dos pacientes acometidos por ameloblastoma.
Palavras-chave: Tumores odontogênicos; Ameloblastoma; Epidemiologia
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IntROduCtIOn
According to the World Health Organization [1], 
ameloblastoma is a benign odontogenic tumor originating 
from the proliferation of odontogenic epithelium without 
involvement of the mesenchymal tissue. It accounts for 1% 
of all tumors of the maxilla as well as 11% of all odontogenic 
tumors. The slow, painless growth of this tumor often results 
in a late diagnosis [2]. Although benign, ameloblastoma is 
locally invasive and therefore surgery with a margin of safety 
is the treatment of choice, which results in considerable 
mutilation in many cases [3,4]. However, the mechanism for 
this invasive behavior remains unknown [1,5,6].
From the clinical-radiological standpoint, ameloblastoma 
is classified as solid or multicystic (70 to 80% of cases), 
unicystic (13%), peripheral or extraosseous (2 to 10%) [1]. 
Clinically, it is most commonly found in the posterior region 
of the mandible (70% of cases) [1,4,7,8]. Histologically, 
ameloblastoma is classified as solid, desmoplastic or 
unicystic [1]. The solid types are subdivided into follicular, 
plexiform (which are the most common), acanthomatous, 
granular cell or basal cell [1]. More than one histological 
types can be found in the same tumor [1,9]. However, there 
is little evidence that these histological types have any 
significance regarding clinical behavior and prognosis. The 
unicystic variant generally affects younger patients (second 
decade of life). This form is considered less invasive and 
consequently associated to more conservative treatment, 
a more favorable prognosis and a lesser incidence of 
recurrence [4,7,8].
There is no consensus in the literature on the most 
appropriate form of treatment for the different types 
of ameloblastoma. Conservative treatment consists of 
enucleation and curettage, followed by cyrotherapy, whereas 
more radical treatment involves marginal resection of the 
affected segment or mandibulectomy/maxillectomy. Due 
to its less aggressive behavior, conservative treatment is 
recommended for a unicystic ameloblastoma [2].
Studies have been published on the profile of patients 
with ameloblastoma and it is reported that geographic 
variations may exert an influence on epidemiological data 
regarding this tumor in different populations [5,10-18] 
(Table 1). The aims of the present study were to perform a 
retrospective analysis of cases of ameloblastoma, compare 
the findings with those described in previous studies and 
outline the epidemiological profile of this type of tumor in 
the Brazilian population.
MethOds
The present retrospective study received approval from 
the Human Research Ethics Committee of the Universidade 
Federal do Rio Grande do Sul (UFRGS, Brazil).
All records of histopathological findings of the 
Histopathology Laboratory of the UFRGS School of 
Dentistry (southern Brazil) between 1954 and 2009 were 
reviewed for the identification of cases with a diagnosis 
of ameloblastoma. Slides stained with hematoxylin & 
eosin were examined under an optical microscope for 
the confirmation of the diagnosis and the findings were 
table 1. Summary of papers with analysis of clinical-demographic data on ameloblastoma.
Authors/year of publication study location sample size Period analyzed Gender Anatomic site ethnic group Age
Chidzonga et al., 1996 Zimbabwe 117 cases 1982 to 1991 Men (53%)
Mandible 
(95.7%)
–
Mean age: 
30 years
Mosqueda-Taylor et al., 1997 Mexico 80 cases 1960 to 1996 Women (55.4%)
Mandible 
(82.4%)
– 11 to 79 years
Junquera et al., 2003 Spain 22 cases 1975 to 2000 Women (59%)
Mandible 
(100%)
22 to 72 years
Fernandes et al., 2005 Brazil 154 cases 1954 to 2004 Women (54.5%)
Mandible 
(85%)
–
Mean age: 
27.7 years
Ledesma-Montes et al., 2007
Mexico and 
Guatemala
163 cases 1959 to 2000 Men (52.8%)
Mandible 
(86.4%)
–
Mean age: 
31.7 years
Adeline et al., 2008 Kenya 184 cases 1995 to 2005 Women (55.4%)
Mandible 
(93.5%)
–
Mean age: 
30.2 years
Tawfik et al., 2010 Egypt 34 cases 1993 to 2008 Men (67.65%)
Mandible 
(94.4%)
–
Mean age: 
34.5 years
Fregnani et al., 2010 Brazil 121 cases 1953 to 2003 Women (53%)
Mandible 
(80%)
Caucasian 
(72%)
18 to 32 years 
(41.3%)
Fulco et al., 2010 Brazil 54 cases Not informed
Women (50%)
Men (50%)
Mandible 
(98.1%)
–
Mean age: 
38.3 years
Krishnapillai, Angadi, 2010 India 73 cases 1989 to 2007 Men (56.1%)
Mandible 
(91.8%)
– 10 to 78 years
Present study Brazil 89 cases 1954 to 2009 Women (58.4%)
Mandible 
(78.6%)
Caucasian 
(62.9%)
10 to 29 years 
(40.2%)
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classified based on the criteria defined by the WHO [1] 
as solid ameloblastoma (subtypes: follicular, plexiform, 
acanthomatous, granular cell and basal cell), desmoplastic 
ameloblastoma or unicystic ameloblatoma. The following 
variables were also analyzed: gender, age, ethnic background, 
anatomic site and histological type. Among the 96 cases 
with a histopathological diagnosis of ameloblastoma, 89 
contained information on these variables and were included 
in the present study.
A database was built using the Excel® program, followed 
by statistical analysis using the Statistical Package for Social 
Sciences® (version 13.0). The level of significance was set to 
5%. Categorical variables were tabulated as follows: gender 
(male and female), ethnic background (Caucasian, African 
descent, other ethnicity and not informed), anatomic site 
(mandible, maxilla and not informed) and histological type 
(follicular, plexiform, acanthomatous, granular cell and 
basal cell). The quantitative variable age was categorized in 
decades of life to facilitate the analysis and comprehension 
of the data. Descriptive statistical analysis was performed 
for the determination of the frequencies of the categorical 
variables studied. 
Results
A total of 32,035 tumors were diagnosed at the UFRGS 
Oral Histopathology Laboratory between 1954 and 2009, 89 
of which were cases of ameloblastoma, accounting for 0.27% 
of the diagnoses. Descriptive analysis was performed based 
on the histopathological diagnosis, patient characteristics 
and anatomical location (Table 2). Among the 89 cases of 
ameloblastoma, 78 were solid tumors (88.6%), two were 
desmoplastic tumors (2.2%) and nine were unicystic tumors 
(10.2%). 
Among the solid tumors, there was a predominance 
of the female gender (56.0%) and Caucasian ethnicity 
(66.7%); most were located in the mandible (76.9%) and 
40.2% occurred prior to the third decade of life. Regarding 
the histological findings, the follicular form was the most 
prevalent (34 cases; 43.68%), followed by the plexiform 
(29 cases; 37.2%), acanthomatous (8 cases; 10.3%) and 
basal cell (5 cases; 6.3%) types. No cases of granular cell 
ameloblastoma were diagnosed. Two cases were classified 
as “not identified” (2.6%) and corresponded to cases with 
more than one histological pattern on the same slide. The 
cases of desmoplastic ameloblastoma occurred in the 
mandible of Caucasian women in the 5th decade of life (one 
of these cases had no information on the ethnic background 
or age of the patient). Unicystic ameloblastoma was more 
prevalent in the female gender (66.7%), affected individuals 
of Caucasian and African descent equally (33.3%), was 
located predominantly in the mandible (88.9%) and occurred 
mostly between the third and sixth decades of life (77.7%) 
(Table 2). 
table 2. Distribution of ameloblastomas according to gender, ethnic background, anatomic site and age group; Porto Alegre, Rio Grande do 
Sul, Brazil, 2010.
Variable
solid ameloblastoma
(n=78) 88.6%
desmoplastic ameloblastoma 
(n=02) 2.2%
unicystic ameloblastoma 
(n=09) 10.2%
total
(n=89) 100%
Gender Male 31 (39.7%) 0 (0%) 03 (33.3%) 34 (38.2%)
Female 44 (56.4%) 02 (100%) 06 (66.7%) 52 (58.4%)
Not informed 03 (3.8%) 0 (%) 0 (0%) 03 (3.4%)
Age 10 to 19 years 10 (12.8%) 0 (0%) 03 (33.3%) 13 (14.6%)
20 to 29 years 22 (28.2%) 0 (0%) 01 (11.1%) 23 (25.6%)
30 to 39 years 15 (19.2%) 0 (0%) 0 (0%) 15 (16.8%)
40 to 49 years 10 (12.8%) 01 (50%) 0 (0%) 11 (12.3%)
50 to 59 years 02 (2.6%) 0 (0%) 03 (33.3%) 05 (5.6%)
60 to 69 years 03 (3.8%) 0 (0%) 0 (0%) 03 (3.8%)
70 to 79 years 05 (6.4%) 0 (0%) 0 (0%) 05 (5.6%)
80 to 89 years 01 (1.3%) 0 (0%) 0 (0%) 01 (1.1%)
Not informed 10 (12.8%) 01 (50%) 2 (22.2%) 13 (14.6%)
Ethnicity Caucasian 52 (66.7%) 01 (50%) 03 (33.3%) 56 (62.9%)
African descent 10 (12.8%) 0 (0%) 03 (33.3%) 13 (14.6%)
Other ethnicity 03 (3.8%) 0 (0%) 01 (11.1%) 04 (4.5%)
Not informed 13 (16.7%) 01 (50%) 02 (22.2%) 16 (18.0%)
Site Mandible 60 (76.9%) 02 (100%) 08 (88.9%) 70 (78.6%)
Maxilla 07 (9%) 0 (0%) 0 (0%) 07 (7.8%)
Extraosseous 02 (2.6%) 0 (0%) 0 (0%) 02 (2.2%)
Not informed 09 (11.6%) 0 (0%) 01 (11.1%) 10 (11.23%)
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dIsCussIOn
The incidence of odontogenic tumors exhibits 
considerable variation in epidemiological studies carried 
out in different countries [5,10-18]. Such variations may 
be explained by geographic, ethnic and socioeconomic 
factors [16] and the large number of reactive/inflammatory 
tumors submitted to histopathological analysis in North 
American countries, which does not occur in Latin American 
countries [11].
Ameloblastoma is the most prevalent odontogenic 
tumor in studies carried out in Brazil (45.2% to 67% of 
cases) [12,16], China (58.6 to 59.4%) [20,21], Nigeria 
(58.5%) [22] and Egypt (41.5%) [14]. However, a number 
of investigations report ameloblastoma to be the second most 
prevalent form of odontogenic tumor, such as studies carried 
out in Canada (17.8% of cases) [22], Mexico (23.7%) [10] 
and Brazil [11]. This difference may be explained by the fact 
that some studies do not include odontoma, which increases 
the relative frequency of ameloblastoma [16].
In the present study, ameloblastoma accounted for 0.27% 
of all tumors analyzed at the UFRGS Oral Histopathology 
Laboratory between 1954 and 2009. This frequency is 
smaller than rates reported in a Latin American population 
[13] and a previous Brazilian investigation [12], which 
describe a frequency of 0.8% and 0.5%, respectively. 
It should be stressed that these greater frequencies were 
due to the fact that the studies cited used both laboratory 
findings and data from hospitals that received patients 
sent for treatment with a previous diagnosis of amelo- 
blastoma.
Among the cases of ameloblastoma analyzed, 88.6% 
were classified as solid, which is in agreement with findings 
described in the literature [14,16,17], with the exception of a 
multicenter study carried out in Latin America, which found 
that solid amelobastoma only accounted for 33.7% of cases 
[13]. In the evaluation of the histological subtypes of solid 
ameloblastomas, the follicular and plexiform patterns were 
the most prevalent, which is in agreement with findings 
described in previous studies [3,14,17]. A number of authors 
state that there is little evidence that these histological 
types have any significance regarding clinical behavior and 
prognosis. However, such concepts remain controversial and 
further studies are needed to clarify this issue.
Desmoplastic ameloblastoma accounted for 2.2% 
of cases in the present study. This is in agreement with 
findings reported in previous investigations [3,13,14,17], 
which report prevalence rates ranging from 0.5% to 5.6%. 
Moreover, Fulco et al. [17] classified 3.7% of cases as hybrid 
tumors formed by masses of desmoplastic ameloblastoma 
with significant areas of solid ameloblastoma.
The prevalence of unicystic ameloblastoma was 10.2% 
in the present investigation. Most studies report a lower 
prevalence rate of this type of tumor, ranging from 4% to 
6% [3,14,16]. The only study to report a greater prevalence 
rate of unicystic ameloblastoma in comparison to solid 
ameloblastoma was carried out by Ledesma-Montes et al. [13], 
in which 63.7% of cases were classified as unicystic 
ameloblastoma. The authors explain this high prevalence 
rate by the technical rigor employed in the differentiation 
of unicystic ameloblastoma from cases diagnosed as solid 
ameloblastoma.
Regarding gender, women were more affected by 
ameloblastoma in the present study (58.4%). Data on gender 
differences vary in the literature. Some studies report an 
equal frequency between men and women [17]; others 
report a predominance of the male gender [10,13,15,18] 
and still others report a predominance of the female gender 
[5,11,12,14,16]. These discrepancies suggest that the 
findings are directly proportional to the profile of the patients 
who seek medical-dental care in each population.
In the present study, 40.2% of the cases of ameloblastoma 
occurred prior to the third decade of life. The literature 
reports considerable variation regarding this variable. 
However, in a meta-analysis on ameloblastoma, Reichart 
et al. [3] report a median age of 34 and 24 years upon the 
initial diagnosis in industrialized and developing countries, 
respectively. 
Studies addressing clinical-epidemiological data on 
ameloblastoma generally do not assess ethnic background, 
as this characteristic is strongly associated with cultural and 
socioeconomic factors. In the present study, ameloblastomas 
occurred with greater frequency among patients of Caucasian 
descent (62.9%), which is in agreement with the 72% 
described by Fregnani et al. [16] in a study on this type of 
tumor in a sample of Brazilians. However, these data cannot 
be extrapolated to the national population, as the population 
of the state of Rio Grande do Sul is 82.3% Caucasian and 
5.9% African descent; moreover, metropolitan Porto Alegre 
is 80.7% Caucasian and 8.0% African descent (IBGE, 
2008) [23]. Therefore, a greater number of biopsies from 
Caucasian individuals are to be expected.
The mandible was the most affected anatomic site 
(78.6% of cases). This finding is in agreement those 
reported in all epidemiological studies on ameloblastoma 
reviewed [3,5,10-13,15,16,18], which demonstrates that 
the anatomic site of ameloblastomas is not associated with 
ethnic, culture or socioeconomic issues. However, we know 
of no explanation for the predominance of the mandible in 
cases of ameloblastoma. 
Due to its retrospective nature, the present study cannot 
provide data on the current prevalence of ameloblastoma. 
However, one may affirm that the tumors studied herein were 
predominantly solid, located in the mandible and affected 
Caucasian women up to 29 years of age more. The only 
characteristic unanimously reported in all populations is 
the preferential location of ameloblastoma in the mandible, 
whereas the prevalence of the other characteristics varies 
in accordance with the demographic characteristics of 
each country. The present findings are in agreement with 
those reported in previous studies carried out in other 
states of Brazil and support that notion of a geographical 
influence on the profile of patients affected by amelo- 
blastoma.
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COnClusIOn
The present findings are in agreement with those reported 
in previous studies carried out in other states of Brazil and 
support that notion that there may be a geographical influence 
on the profile of patients affected by ameloblastoma.
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